%0 Journal Article
%A Vázquez-Alonso, F
%A Puche-Sanz, I
%A Sánchez-Ramos, C
%A Flores-Martín, J
%A Vicente-Prados, J
%A Cózar-Olmo, J M
%T Primary renal lymphoma: long-term results of two patients treated with a chemotherapy + rituximab protocol.
%D 2012
%U http://hdl.handle.net/10668/807
%X Primary renal lymphoma (PRL) is a rare disease of which the etiology and pathogenesis remain controversial, and there is currently no standard treatment for it. We present the results of a long-term followup of two patients who were diagnosed with PRL and treated with cyclophosphamide, adriamycin, vincristine, prednisolone and rituximab (CHOP + R) regimen. Both patients reached a complete response, and there is no evidence of recurrence after 4.5- and 5-year followup periods. Based on our experience and other recently published studies, we recommend the combination of CHOP + rituximab as the elective treatment for this disease. To our knowledge, this is the longest followup period with a complete response that has been reported with this modality of treatment.
%K Linfoma
%K Antineoplastic Agents
%K rituximab
%K Antineoplásicos
%K Anticuerpos Monoclonales
%K Ciclofosfamida
%K Doxorrubicina
%K Vincristina
%K Prednisolona
%K R-CHOP protocol
%K Neoplasias Renales
%~